Hussman Strategic Advisors’s St Jude Medical STJ Stock Holding History

Hussman Strategic Advisors’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-70,000	Closed	-$4.42M	–	264
2015 Q3	$4.42M	Buy	+70,000	New	+$5M	0.56%	70
2014 Q4	–	Sell	-250,000	Closed	-$15M	–	233
2014 Q3	$15M	Hold	250,000	–	–	1.28%	11
2014 Q2	$17.3M	Sell	250,000 -50,000	-17%	-$3.24M	1.33%	16
2014 Q1	$19.6M	Sell	300,000 -50,000	-14%	-$3.25M	1.47%	11
2013 Q4	$21.7M	Buy	+350,000	New	+$20.3M	1.54%	6
2013 Q3	–	Sell	-4,900	Closed	-$224K	–	254
2013 Q2	$224K	Buy	+4,900	New	+$212K	0.01%	182

Other funds holding STJ

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Hussman Strategic Advisors's STJ Position: Q4 2015 in Review

Hussman Strategic Advisors sold out of St Jude Medical (STJ) in Q4 2015, closing a stake of 70,000 shares — an estimated $4.42M sold.

Hussman Strategic Advisors first reported a position in STJ in Q2 2013 and held it in 6 quarters. The position peaked at $21.7M in Q4 2013. 620 funds tracked by Wall St. Rank hold STJ as of Q4 2015.

Hussman Strategic Advisors reported no remaining St Jude Medical position as of Q4 2015 after selling out during the quarter.
Hussman Strategic Advisors sold 70,000 St Jude Medical shares in Q4 2015, an estimated $4.42M.
Hussman Strategic Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 6 quarters.
Hussman Strategic Advisors's St Jude Medical position peaked at $21.7M in Q4 2013.
620 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2015.

Based on Hussman Strategic Advisors's 13F filing for Q4 2015, filed 1 Feb 2016.